ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 584,75
-0,63%
Dow Jones
40 211,72
0,53%
DAX
18 487,08
-0,61%
Brent Oil
83,705
-0,75%
Bitcoin
63 104,90
-2,69%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
21/06/202114h01Business WireNew Data Supporting the Safety & Efficacy Profile of AJOVY® (fremanezumab) Shared at 7th European Academy of Neurology Congr...NYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/202114h23Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/202113h36Business WireTeva Announces the U.S. Launch of its Generic Version of SOOLANTRA® (ivermectin) Cream, 1% for Once Daily Treatment of RosaceaNYSE:TEVATeva Pharmaceutical Industries Ltd
03/06/202114h15Business WireNew Clinical & Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection Presented at 2021 American Headac...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/06/202114h00Business WireTeva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2021 American Headache Society (AHS) Annual Meeti...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202119h03Business WireTeva Announces the U.S. Launch of the First Generic Version of THIOLA® (tiopronin) tabletsNYSE:TEVATeva Pharmaceutical Industries Ltd
17/05/202114h00PR Newswire (US)Teva Launches 'It's Not OK - It's TD' National Television Advertising Campaign to Increase Awareness of Tardive Dyskinesia an...NYSE:TEVATeva Pharmaceutical Industries Ltd
10/05/202114h00Business WireTeva to Highlight Research in Respiratory Care at Upcoming 2021 American Thoracic Society International ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
05/05/202114h00Business WireTeva Announces New Environmental, Social and Governance (ESG) Strategy and Goals in 2020 ReportNYSE:TEVATeva Pharmaceutical Industries Ltd
04/05/202117h14Business WireTeva Announces Launch of its Generic Erythromycin Tablets USP, Used to Treat or Prevent a Variety of Bacterial Infections, in...NYSE:TEVATeva Pharmaceutical Industries Ltd
03/05/202114h00Business WireTeva to Present New Long-Term AUSTEDO® (deutetrabenazine) Tablets Data at American Psychiatric Association Annual MeetingNYSE:TEVATeva Pharmaceutical Industries Ltd
29/04/202122h18Business WireTeva Announces the Launch of the First Generic Version of Absorica® (isotretinoin) Capsules, for the Treatment of Severe Rec...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202122h08Edgar (US Regulatory)Quarterly Report (10-q)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202113h01Edgar (US Regulatory)Current Report Filing (8-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
28/04/202113h00Business WireTeva Reports First Quarter 2021 Financial ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
27/04/202114h00Business WireTeva to Present New Analyses of AUSTEDO® (deutetrabenazine) Tablets & Assessment of Schizophrenia Clinical Outcomes at Upcom...NYSE:TEVATeva Pharmaceutical Industries Ltd
23/04/202117h09Business WireTeva Announces Launch of its Generic Version of Canasa® (mesalamine) Suppositories To Treat Adults with Active Ulcerative Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/04/202122h12Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NYSE:TEVATeva Pharmaceutical Industries Ltd
20/04/202101h55Dow Jones NewsDrugmakers Accused of Causing Opioid Addiction in Trial -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/202123h42Dow Jones NewsDrugmakers Accused of Causing Opioid Addiction in TrialNYSE:TEVATeva Pharmaceutical Industries Ltd
19/04/202114h00Business WireNew Clinical & Real-World Data Evaluating Efficacy of AJOVY® (fremanezumab-vfrm) Injection & Reduction of Migraine Burden Pr...NYSE:TEVATeva Pharmaceutical Industries Ltd
18/04/202117h29Dow Jones NewsDrugmakers Go on Trial Over Opioid EpidemicNYSE:TEVATeva Pharmaceutical Industries Ltd
15/04/202114h00Business WireTeva to Present New Analyses of AJOVY® (fremanezumab-vfrm) Injection & AUSTEDO® (deutetrabenazine) Tablets at Upcoming 2021...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202113h30Business WireTeva Canada annonce le lancement du nouvel auto-injecteur AJOVYMD pour le traitement préventif de la migraine chez les adultesNYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h49TipRanksTeva’s Seffalair And BroPair Spiromax Receive Approval In EUNYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h15Business WireTeva reçoit l'autorisation de mise sur le marché de l'UE pour Seffalair® Spiromax® et BroPair® Spiromax® (xinafoate de ...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202112h09Business WireTeva erhält EU-Marktzulassung für Seffalair® Spiromax® und BroPair® Spiromax® (Salmeterol Xinafoate / Fluticasone Propi...NYSE:TEVATeva Pharmaceutical Industries Ltd
08/04/202109h00Business WireTeva receives EU Marketing Authorisation for Seffalair® Spiromax® & BroPair® Spiromax® (salmeterol xinafoate / fluticason...NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202115h42Business WireTeva to Host Conference Call to Discuss First Quarter 2021 Financial Results at 8 a.m. ET on April 28, 2021NYSE:TEVATeva Pharmaceutical Industries Ltd
06/04/202113h30Business WireTeva Canada amplifie son engagement envers les aidants canadiens et présente de nouvelles ressources pour soutenir et améli...NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

BIT
P1MD37
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés